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     Abstract   
Background: The present investigation of a mangrove plant, Excoecaria agallocha, which is a popular medicinal 
substitute for the treatment of microbial ailments, were evaluated for potential antimicrobial activity against 
pathogenic bacteria Escherichia coli and Streptococcus agalactiae in tilapia, Oreochromis niloticus. 
Methods: Antibacterial activity was performed using agar diffusion method, disc diffusion method, minimum 
inhibitory concentration (MIC), minimum bactericidal concentration (MBC), and antibiotic susceptibility assays. 
Experimental fish fed diet containing 0 (control), 5, 25, and 50 mg kg-1 E. agallocha leaf methanol extract for 28 
days then challenged individually with E. coli or S. agalactiae and mortalities were recorded over a ten-day post-
infection period.   
Results: Results indicated that both bacterial species are sensitive to tetracycline, ampicillin, and amoxicillin. E. 
coli was found to be resistant to neomycin. E. agallocha extract concentration of 50 mg/ml produced a zone of 
inhibition of 18 mm against E. coli, in contrast to 13 mm against S. agalactiae.  E. agallocha showed bactericidal 
activity against E. coli and bacteriostatic activity against S. agalactiae. The highest E. agallocha LC50 activity was 
83 mg/ml. The highest cumulative mortality was 90.0 ± 10.0% in control as compared to 26.7 ± 11.5% in the group 
fed with 50 mg kg-1 E. agallocha extract, significant differences (P < 0.05). 
Conclusion: Hence, E. agallocha showed antibacterial activity against fish pathogens Escherichia coli and 
Streptococcus agalactiae in tilapia, Oreochromis niloticus; therefore, E. agallocha may be used as an alternative 
therapeutic agent against fish pathogenic bacteria as an additive to feed at a concentration depend, safe, non-
cytotoxic doses. 
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Background   
The Bacterial infections in aquaculture are a rising concern 
across the globe. The effectiveness of conventional antibiotics 
is decreasing due to the global emergence of multi-drug 
resistant (MDR) bacterial pathogens. The use of broad-spectrum 
antibacterial agents has led to one of the largest recent global 
health problems as a result of the development of bacterial 
resistance. Several bacterial species have developed multidrug 
resistance, including Escherichia coli [1].  
     E. coli is a common disease of freshwater fish, especially 
under cultured conditions [2], and has an important role in 
economic losses among the fish industry. This pathogen has a 
variable clinical course ranging from mild to severe infection, 
possibly leading to death due to septicemia, depending on the   
bacterial strain and its virulence as well as host-related factors 
such as age and immunity [3]. Likewise, Streptococcus 
agalactiae is an important human and animal pathogen 
associated with a variety of diseases in fish [4]. Septicemia is a 
common condition in tilapia fish infected with Streptococcus 
agalactiae [5] becoming highly problematic in freshwater fishes, 
constantly threatening the sustainability of the global tilapia 
aquaculture industry [6]. Therefore, efforts have been now 
shifted to focus on identifying novel drugs of natural plant 
sources to be used as an alternative to antibiotics in disease 
management in aquaculture [7].   
     Excoecaria agallocha contains a copious number of 
polyphenols and terpenoids, which have been reported to have 
an epidemic and endemic disease control as an antimicrobial, 
anti-cancer, and anti-diabetic agent [8]. However, there is 
sparse information regarding the capability of E. agallocha for 
the treatment of infections caused by aquaculture bacterial 
pathogens [9-11]. Thus, new compounds that target bacterial 
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virulence can be developed to control the threat posed by 
multidrug resistance found in economically valuable fish. The 
search for a new treatment is urgently needed predominantly in 
those who are non-therapeutic in nature as well as being 
environmentally friendly. Therefore, the objective of this study 
was conducted to evaluate the effect of food additive with E. 
agallocha leaf methanolic extract on artificially infected tilapia, 
Oreochromis niloticus, with zoonotic bacteria Escherichia coli 
and Streptococcus agalactiae. 
 
Methods 
Preparation of plant and extraction                                                                                                           
Excoecaria agallocha leaves were collected from the east coast 
in Terengganu and was identified at the Plant Taxonomy 
Laboratory in University Malaysia Terengganu (UMT). The 
leaves were washed and air-dried in the oven overnight at 40°C. 
The leaves were then ground to a fine powder using a blender, 
weighing 1 kg. Then, 25 g of plant sample was Soxhlet 
extracted with 250 mL of MeOH at 60°C for 12 h [12]. Extracts 
in methanol solvents were evaporated and concentrated to 
dryness using a rotary evaporator at 45°C. The weight after 
extraction was determined, and the percent yield (%) for 
extraction was calculated [11]. 
 
Microbial assessment  
Fish pathogens as One Gram-negative bacteria Escherichia coli 
and One Gram-positive bacteria Streptococcus agalactiae, 
deposited in GenBank (Accession No. KT869025), were used in 
this study. Both were obtained from Fish Disease Laboratory, 
School of Fisheries and Aquaculture Sciences, University 
Malaysia Terengganu (UMT), Malaysia. 
 
Antibiotics susceptibility test 
Antibiotics resistance patterns were determined using the disk 
diffusion method, according to CLSI [13]. 
 
Antibacterial assay   
Disk diffusion assay was carried out on Mueller Hinton Agar 
(MHA) following the methods described by Barker [14], and 
the agar well diffusion method, according to Perez [15]. 
 
Determination of MIC and MBC  
The minimum inhibitory concentration (MIC) was determined 
using the broth dilution assay technique in 96 wells microtiter 
plates. This method was carried out according to CLSI [13], 
while the minimum bactericidal concentration (MBC) extract 
was determined according to Ilavenil [16]. 
 
Toxicity test  
Brine shrimp lethality assay was carried out to study the general 
toxicity of the extract of E. agallocha according to the methods 
of Pisutthanan [17]. 
 
Determination of the Median Lethal Dose (LD50)  
All assays in experimental fish were divided into two main 
groups. The first group was challenged with E. coli, and the 
second group challenged with S. agalactiae, individually. Both 
were challenged under the same environmental laboratory 
conditions. 
Fish collection and acclimatization 
Healthy juvenile tilapia, O niloticus, (3.5 ± 0.2 g) were obtained 
from UMT hatchery. Fish were acclimatized to laboratory 
conditions for 14 days and then stocked into 16 composite tanks 
(20 L) in a flow-through freshwater supply system, fed twice a 
day a commercial feed (30% crude proteins). Water temperature 
(26 ± 2°C), dissolved oxygen (DO) (5.57 ± 0.01 mg/L) and pH 
was (7.2 ± 0.2) ranged on acceptable values throughout the 
experimental period. These were measured with (YSI -Yellow 
Springs Instruments - model 85/10). 
 
Prepare Bacteria Inoculum
The stock bacteria of E. coli or S. agalactiae were first passed 
through healthy fish to potentiate its virulence. Then they were 
grown on blood agar (Oxoid, U.K.) at 28°C for 24 to 48 hours. 
Bacterial cells were washed twice with physiological saline and 
then re-suspended in the same solution to obtain a bacterial 
suspension. The bacteria suspension was adjusted to McFarland 
turbidity standard No.5 equivalent to 15x108cfu mL 1. Ten-fold 
serial dilutions were done to obtain a different concentration of 
bacteria. Intra-peritoneal injection method (i.p.) inoculated into 
tilapia, O niloticus. 
 
Experimental design 
The LD50 value was determined to obtain the lowest bacterial 
dose of E. coli or S. agalactiae (individually) that cause 50 % 
mortality in tilapia, O niloticus. Six groups of tilapia, O 
niloticus, with ten fishes per group, were housed in a 20 L 
aquarium supplied with proper aeration. The environmental 
conditions were maintained as optimum as possible. The 
temperature was kept at 26 ± 2°C, dissolved oxygen (DO) was 
5.4 ± 0.5 mg L-1, and pH was 7.2 ± 0.2. Fish were kept in a 
fasting state for 24 h before beginning the experiment.  
      The fishes were anesthetized using Tricaine Methane 
sulfonate (MS-222) (Sigma, Aldrich). The fish in groups 1, 2, 3, 
4 and 5 were artificially injected intraperitoneally (i.p.) with 0.1 
ml of culture suspension of pathogenic E. coli or S. agalactiae 
containing 15 x 108, 15 x 107, 15 x 106, 15 x 105 and 15 x 104 
CFU mL-1, respectively. The 6th group, control group, was 
injected intraperitoneally (i.p.) with 0.1 ml with physiological 
saline. Fish mortality was recorded every 24 h for ten days. 
Dead fish were removed from the aquarium daily. 
 
Efficacy of dietary doses of E. agallocha on disease 
resistance  
 
Preparation of E. agallocha diets 
During the acclimation period of 14 days, fish were fed with 
commercial diets (Analytical Laboratories of UMT hatchery) at 
3% BW d-1 twice a daily between the hours of 8.00-9.00 and 
15.00- 16.00. During the experimental period, the fish were fed 
for 28 days with 5, 25, and 50 mg extract per -1 kg food, 
respectively, and the basal diet acted as controls. The extract at 
a concentration of 5, 25, and 50 mg was dissolved in distilled 
water and sprayed on the thin layer of basal food. The pellets 
were dried in an oven at 30°C for 18 h, packed in polythene 
bags and stored in a freezer at -20°C until used. All fish were 
deprived of food for 24 h before the challenge test. 
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Experimental design 
A total of 300 healthy juvenile tilapia, Oreochromis niloticus, 
(3.5 ± 0.2 g) were obtained from UMT hatchery. Fish were 
acclimatized for 14 days before being used for experiments. The 
experimental fish were divided into two groups; the first group 
was the control group, included positive and negative fed basic 
diet (no additive of plant extract). The second group acted as a 
treatment group, which consisted of three subgroups which 
received three different levels of E. agallocha leaf methanol 
extract at concentration 5, 25, and 50 mg kg-1, respectively. 
Each group for three replicates (10 fish per 20L tank). Fish were 
fed at 3% BW d-1 twice daily (9:00 and 18:00) for 28 days. On 
the 29th day, all fish in the treatment group were injected 
intraperitoneally (i.p.) with 100 μl bacteria S. agalactiae at dose 
15×105 CFU mL-1 (This dose was calculated previously from 
the determination of Lethal dose LD50). Meanwhile, negative 
control groups were injected intraperitoneally (i.p.) with 100 μl 
bacteria S. agalactiae at dose 15×105 CFU mL-1. The positive 
control group was injected intraperitoneally (i.p.) with 100 μl 
physiological saline. The same design applied but a different 
type of bacteria, using E. coli at dose 15×108 CFU mL-1. The 
cumulative mortality was monitored for a group of fishes in all 
experiments for ten days post-infection. 
 
Disease resistance 
The effect of E. agallocha leaf extract incorporated feed for the 
disease resistance (survival percentage) on fish (n = 10/group) 
was determined. The fish were artificially challenged with a 
dose of 15×105 CFU mL-1, 15×108 CFU mL-1 of live virulent  
pathogen S. agalactiae, and E. coli, respectively.  
The mortality was observed for ten days, and the average of the 
triplicate set was used to express in terms of percentage of 
survival. 
 
Statistical analysis 
Effects of E. agallocha diets on survival were expressed as the 
arithmetic mean ± standard division (SD) by using Tukey 
statistical analysis using one-way analysis of variance 
(ANOVA) to reveal the significant difference between the 
treatments at the 5% (P < 0.05) level of significance by using 
SPSS version 20.0 for windows. Data were expressed as 
concentration ± mortality (%) of triplicate measurements. Probit 
analysis was used to determine 120 h (LD50) and (LC50) using 
SPSS 20.0. 
 
Results  
Clinical signs 
There were no clinical signs apparent on the experimental fish 
infected with E. coli and S. agalagtiae except for sudden death 
and petechial hemorrhages on the site of injection in some fish. 
 
Antibiotic assay 
Antibiotic susceptibility test was done on selected samples of 
gram-positive S. agalactiae and gram-negative bacteria E. coli. 
The inhibition zone (mm) was recorded for five types of 
antibiotics. Both isolates showed 100% sensitivity to 
amoxicillin, ampicillin, and tetracycline. However, gram-
negative bacteria E. coli isolates showed resistance to neomycin 
(Table 1 & Fig. 1, 2). 
 
 
Table 1: Antibiotic susceptibility test of Escherichia coli and Streptococcus agalactiae by agar disc diffusion method 
Antibiotic  Disc potency (mcg) Isolates Diameter Zone of Inhibition (mm)  
  E. coli S. agalactiae R I S 
Amoxicillin 10  22/ S 20/ S 13 14-17 18 
Neomycin 30 12/ R 19/ S 12 13-15 17 
Penicillin 10 23/ I 24/ I 20 21-28 29 
Ampicillin 10 20/ S 18/ S 14 15-16 17 
Tetracycline 30 20/ S 20/ S 14 15-18 19 
*R=resistance, I= intermediately sensitive, S=sensitive. 
 
 
 
Figure 1: Zone inhibition of antibiotic susceptibilities: A=Neomycin (N 30ug),                Figure 2: Zone inhibition of antibiotic susceptibilities: A=Neomycin (N 30ug),                                
B=Amoxicillin (AML 10 ug), C=Ampicillin (AMP 25ug), D=Penicillin                   B=Amoxicillin (AML 10 ug), C=Ampicillin (AMP 25ug), D=Penicillin (P 10ug), 
 (P 10ug), E=Tetracycline (TE 30ug) against Escherichia coli.                            E=Tetracycline (TE 30ug) against Streptococcus agalactiae. 
Antibacterial assay 
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The mean zone of inhibition for E. agallocha methanol extracts 
of concentration 5, 25, and 50 mg/ml using the disk diffusion 
method were 10, 12, and 14mm against E. coli and 7, 9 and13 
mm, against S. agalactiae, respectively (Table 2 & Fig. 3). In 
using a suitable diffusion method, results showed 13, 15,  
 
and 18mm against E. coli and 7, 9, and 13mm against S. 
agalagtiae, respectively (Table 3 & Fig. 4). The lowest MIC and 
MBC values for the E. agallocha against E. coli were 3.12 and 
6.25 mg/ml, and 6.25 and 25 mg/ml against S. agalactiae, 
respectively (Table 4). 
Table 2. Comparison of antimicrobial activities of Excoecaria agallocha leaf methanol extract on test organisms by agar disc diffusion method 
 
 
Figure 3: Antibacterial activity of Excoecaria agallocha against test organisms by disc diffusion; (a) Escherichia coli, (b) Streptococcus agalactiae; 1=5mg/ml, 2=25mg/ml, 
3=50mg/ml (Excoecaria agallocha extract); A= Tetracycline (TE 30ug), B=DMSO. 
 
Table 3. Comparison of antimicrobial activities of Excoecaria agallocha leaf methanol extract on test organisms by agar well diffusion method 
 
 
 
Figure 4: Antibacterial activity of Excoecaria agallocha against test organisms by agar well diffusion; (a) Escherichia coli, (b) Streptococcus agalactiae; 1=5mg/ml, 
2=25mg/ml, 3=50mg/ml (Excoecaria agallocha extract) ; A= Tetracycline (TE 30ug), B=DMSO. 
Microorganisms Diameter Zone of Inhibition (mm)   
Excoecaria agallocha extract Tetracycline (30 ug) Control 
  5 mg/ml 25 mg/ml 50 mg/ml 
 
 
Escherichia coli 10 12 14 21 0.0 
Streptococcus agalactiae 7 9 13 15 0.0 
Microorganisms Diameter Zone of Inhibition (mm) 
 
Excoecaria agallocha extract Tetracycline (30 ug) Control 
  5 mg/ml 25 mg/ml 50 mg/ml 
 
 
Escherichia coli 13 15 18 14 0.0 
Streptococcus agalactiae 7 9 13 12 0.0 
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Table 4. Minimum Inhibitory Concentration (MIC) and 
Minimum Bactericidal Concentration (MBC) (mg/ml) of 
Excoecaria agallocha leaf methanol extract on test organisms  
Bacteria MIC MBC MBC/MIC 
Escherichia coli 3.12 6.25 2 
Streptococcus agalactiae 6.25 25 4 
 
Toxicity test 
The toxicity of the brine shrimp test was analyzed by Excel to 
obtain the 50% lethality concentration (LC50), showing the 
value of LC50 to be 83 mg/ml (Fig. 5).  
 
 
Figure 5: Brine shrimp toxicity test at 50% lethality concentration (LC50) 
 
Disease Resistance  
Total mortalities recorded during the experiment were attributed 
to the challenge infection with pathogenic bacteria E. coli and 
S. agalactiae. These mortalities were observed from the first day 
until the fifth day in fish injected with S. agalactiae and sixth 
day in fish injected with E. coli post-challenge. There were no 
mortalities up to 10 days post-challenge. Among the treatment 
groups that were challenged with S. agalactiae, the highest 
cumulative mortality was 90.0±10.0 % in the control group as 
compared to 26.7±11.5%, with the group fed with 50 mg kg-1 
of E. agallocha, a significant difference (p<0.05) (Table 5 & Fig 
6). On the other hand, the cumulative mortality was 
70.0±17.3%, and 40.0±0.0% in the group fed with 5 mg kg-1 
and 25 mg kg-1 of E. agallocha leave crude extract, 
respectively, with significant difference (p<0.05) (Table 6 & 
Fig. 7). In contrast, the control group challenged with E. coli 
showed the highest cumulative mortality was 100.0 ±0.0 % as 
compared to 37.0±5.7% in the group fed at 50 mg kg-1 of E. 
agallocha extract, a significant difference (p<0.05). Moreover, 
the cumulative mortality was 73.3±5.7% and 47.0±5.7% in the 
group fed with 5 mg kg-1 and 25 mg kg-1 of E. agallocha, 
respectively, with significant difference (p<0.05) (Table 6 & 5). 
To best our knowledge, this study was the first, which discussed 
the gender differences in the domains of emotional exhaustion 
among a sample of medical doctors in Iraq and Arab region 
using the validated MBI questionnaire.  
 
Figure 6: Cumulative mortality (%) of tilapia, Oreochromis niloticus fed with 
Excoecaria agallocha supplementation diets and challenged with Streptococcus 
agalactiae for 10 days. Values are mean ±SD of triplicate. 
 
 
Figure 7: Cumulative mortality (%) of tilapia, Oreochromis niloticus fed with 
Excoecaria agallocha supplementation diets and challenged with Escherichia coli 
for ten days. Values are mean ±SD of triplicate. 
 
Discussion 
Mangroves are biochemically unique, producing a wide range 
of novel natural products. In this study, the antimicrobial 
activity of Excoecaria agallocha was established on pathogenic 
bacteria Escherichia coli and Streptococcus agalactiae in fish. 
Antimicrobial agents can be defined as substances that can kill 
and/or inhibit the growth of microorganisms. The antimicrobial 
action of such compounds is related to the inactivation of 
cellular enzymes or by membrane permeability changes causing 
a loss of cellular integrity and eventual cell death [18].  
     Mangrove plants are a rich source of bioactive composites 
and are utilized in many parts of the world as a renewable 
resource and as a treatment option to medical illness in various 
cultural communities globally. Nowadays, mangrove plants 
play a significant role in the treatment of aquatic and fish 
disease because of the minimal side effects and therapeutic 
potential [11]. The present study focuses on the use of E. 
agallocha leaf extract to control bacterial infection in fish. E. 
agallocha extract exhibited significant in vitro antibacterial 
activity against bacteria. Similarly, Laith [11] observed in 
previous studies that E. agallocha extract exhibited antibacterial 
activity against fish pathogens bacteria, including 
Flavobacterium Indicum, Chryseobacterium indologenes, 
Chryseobacterium gleum, and Elizabethkingia meningoseptica. 
Moreover, our findings receive support from the works of 
Bakshi [19] who recorded the antimicrobial activity of leaf 
extracts of mangrove plants: Avicennia alba, Avicennia marina, 
Avicennia officinalis, Excoecaria agallocha, Sonneratia 
caseolaris, Sonneratia apetela, Aegiceres corniculatum, 
Acanthus ilicifolius, Nypa fruticans, and Ceriops decandra  to 
have inhibitory effect against Escherichia coli  with the most 
active extracts being from Excoecaria agallocha plant with a 
zone of inhibition of 10.3 mm.  
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Table 5. Cumulative mortality (%) of tilapia, Oreochromis niloticus treated with Exoecaria agallocha and challenged with Streptococcus agalactiae 
for ten days. Values are mean ±SD of triplicate. Means with the same letters were not significantly different (p>0.05). 
Treatment/Number of days Control (+Ve) Control (-Ve) 5 mg/kg 25 mg/kg 50 mg/kg 
1 0.0 ±0.0a 36.7 ±5.8b 30 ±10.0bc 20.0 ±0.0b 16.7 ±5.8b 
2 0.0 ±0.0a 63.3 ±5.8c 53.3 ±11.5c 30.0 ±0.0b 23.3 ±5.8b 
3 0.0 ±0.0a 80.0 ±0.0c 70 ±17.3c 40.0 ±0.0b 26.7 ±11.5b 
4 0.0 ±0.0a 86.7 ±5.8c 70 ±17.3c 40.0 ±0.0b 26.7 ±11.5b 
5 0.0 ±0.0a 90.0 ±10.0c 70 ±17.3c 40.0 ±0.0b 26.7 ±11.5b 
6 0.0 ±0.0a 90.0 ±10.0c 70 ±17.3c 40.0 ±0.0b 26.7 ±11.5b 
7 0.0 ±0.0a 90.0 ±10.0c 70 ±17.3c 40.0 ±0.0b 26.7 ±11.5b 
8 0.0 ±0.0a 90.0 ±10.0c 70 ±17.3c 40.0 ±0.0b 26.7 ±11.5b 
9 0.0 ±0.0a 90.0 ±10.0c 70 ±17.3c 40.0 ±0.0b 26.7 ±11.5b 
10 0.0 ±0.0a 90.0 ±10.0c 70 ±17.3c 40.0 ±0.0c 26.7 ±11.5b 
 
Table 6. Cumulative mortality (%) of tilapia, Oreochromis niloticus treated with Exocaria agallocha and challenged with Escherichia coli for ten 
days. Values are mean ±SD of triplicate. Means with the same letters were not significantly different (p>0.05). 
Treatment/Number of days Control (+Ve) Control (-Ve) 5 mg/kg 25 mg/kg 50 mg/kg 
1 0.0 ±0.0a 37.0 ±5.7c 23 ±5.7bc 20 ±10.0b 23 ±0.0ab 
2 0.0 ±0.0a 73 ±5.7d 43 ±5.7c 33 ±5.7bc 33 ±5.7b 
3 0.0 ±0.0a 100 ±0.0d 53 ±5.7c 43 ±5.7bc 37 ±5.7b 
4 0.0 ±0.0a 100 ±0.0d 63 ±5.7c 47 ±5.7b 37 ±5.7b 
5 0.0 ±0.0a 100 ±0.0e 70 ±0.0d 47 ±5.7c 37 ±5.7b 
6 0.0 ±0.0a 100 ±0.0c 73 ±5.7d 47 ±5.7b 37 ±5.7b 
7 0.0 ±0.0a 100 ±0.0c 73 ±5.7d 47 ±5.7b 37 ±5.7b 
8 0.0 ±0.0a 100 ±0.0c 73 ±5.7d 47 ±5.7b 37 ±5.7b 
9 0.0 ±0.0a 100 ±0.0c 73 ±5.7d 47 ±5.7b 37 ±5.7b 
10 0.0 ±0.0a 100 ±0.0c 73 ±5.7d 47 ±5.7b 37 ±5.7b 
 
In vitro assays indicated that the growth of the tested fish 
pathogens was suppressed by E. agallocha extract. Gram-
negative bacteria E. coli showed a high inhibition zone of 18 
mm as compared to 13 mm from Gram-positive bacteria S. 
agalactiae. These results were confirmed by in vivo assays 
which showed cumulative mortality to be 26.7 ± 11.5% in the 
group fed with 50mgkg-1 of E. agallocha leave crude extract 
injected with gram-positive S. agalactiae, while this percentage 
was 37.3 ± 5.7% of the same concentration dose of plant extract 
but injected with gram-negative E. coli. Jayanta [20] reported 
that both methanol and aqueous extract of E. agallocha were 
effective against E. coli. These findings are in agreement with 
Agoramoorthy [21], who determined that antimicrobial 
compounds extracted from plant sources are considered to be 
more active on Gram-negative than Gram-positive bacteria due 
to cell wall structure differences among the two. Similar results 
were also obtained by Laith [22] in that active constituents of 
plants interfere with the growth and metabolism of 
microorganisms in a negative manner. Moreover, 
Packialakshmi [23] evaluated the antibacterial activity of 
aqueous E. agallocha leaf extracts using the disc diffusion 
method against gram-negative and positive bacteria.  
     The result revealed that the gram-negative bacteria: 
Escherichia coli, Pseudomonas aeruginosa, and Klebsiella 
pneumonia had a higher inhibition zone of 17, 15, and 16 mm, 
respectively, as compared to gram-positive bacteria 
Staphylococcus aureus and Bacillus subtilis with zones of 15, 
14 mm, respectively. This antibacterial activity that is possessed 
by E. agallocha against infectious pathogens, as shown in this 
study, may be attributed to the presence of diterpenes and 
benzoxazole derivatives and other bioactive compounds found 
in this mangrove plant [24]. In contrast, our results were not in 
agreement with the findings of Rajia [25] who stated that 
methanol extract of E. agallocha did not show any antibacterial 
activity against the clinical isolates; gram-positive bacteria, 
Staphylococcus aureus and Bacillus subtilis, or gram-negative 
bacteria Escherichia coli, Pseudomonas aeruginosa and 
Pseudomonas Vulgaris at different concentrations of 1, 2 and 3 
mg/ml due to bacterial resistance which could cause this 
ineffectiveness of the mangrove extract. Nonetheless, Laith [11] 
indicated that E. agallocha leaf extracts displayed antimicrobial 
activity due to secondary metabolites, and the potential 
mechanisms of these components on bacteria may be related to 
the alteration in bacteria cell wall structures and inhibition of 
bacterial proteins. MIC and MBC values are used to assess the 
antimicrobial efficacy of metabolites or synthetic compounds of 
E. agallocha [26]. Therefore, MIC and MBC values are useful 
as guidelines to choose the appropriate and effective 
concentrations for therapeutic substances [27]. In this study, it 
was determined that the lowest MIC and MBC values for the E. 
agallocha against E. coli were 3.12 and 6.25 mg/ml, and 6.25 
and 25 mg/ml against S. agalactiae, respectively. Similar results 
observed by Jayanta [20] who determined the MIC values of E. 
agallocha against Streptococcus aureus, Pseudomonas 
aeruginosa, Staphylococcus epidermidis, Bacillus subtilis, and 
E. coli ranged from 5 to 7 mg/ml. Similar observations were 
recorded by Selvam [28] in that the MIC of mangrove plants 
tested against bacterial pathogens ranged between 20 mg/ml to 
640 mg/ml. According to Manilal [29], a substance is 
considered bactericidal when the ratio of MBC/MIC ≤ 2, is 
bacteriostatic if the ratio of MBC/MIC ≥ 2 and is ineffective if 
the ratio of MBC/MIC ≥ 16. Therefore, it was concluded that E. 
agallocha leaf extract was bactericidal against E. coli and 
bacteriostatic against S. agalactiae. Additionally, the toxicity of 
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plant extract plays an important role in medicine; therefore, 
brine shrimp larvae bioassay, which is a simple and useful tool 
for the isolation of potentially cytotoxic compounds from plant 
extracts [10], was used to determine the toxic level of extract 
substance. In this study, the LC50 value of E. agallocha was 83 
mg/ml, similar to the results observed by Laith [10], who 
recorded the LC50 value of E. agallocha to be 94.19 mg/ml. 
The difference in values of LC50 may be attributed to the 
different locations of the mangrove plant. Antimicrobial 
resistance is a progressively global problem, and the emerging 
antimicrobial resistance has become a major public health issue 
[30]. Our result revealed E. coli was resistant to neomycin and 
susceptible to tetracycline, which is similar to observations 
recorded by Noryawati [31] in that isolated E. coli was the most 
sensitive to tetracycline. Also, our finding is supported by the 
works of Sabarinath [32], who stated that E. coli was 
susceptible to neomycin and even to Kibret [33], who said that 
E. coli was resistant to tetracycline. Bacteria resistance towards 
antibiotics might be due to their close genetic relatedness [34]. 
Moreover, sudden death was the most common sign of tilapia 
fish infected with E. coli and S. agalactiae. This can be 
attributed to septicemia caused by theses pathogenic bacteria [3, 
5]. Regarding the overall survival rate, the present study 
revealed that E. agallocha leaf extracts increased the survival 
rate of fish after a challenge trial with E. coli and S. agalactiae. 
The highest survival rate was in the group fed at 50 mg kg-1, 
and the lowest survival was observed in control. This finding is 
supported by the works of Pavaraj [35] in common Carp 
(Cyprinus carpio) administered with plant extract of Ocimum 
sanctum and challenged with Aeromonas hydrophila showed no 
mortality as compared to control group which showed 40% 
mortality. Decreased cumulative mortality of fish fed with E. 
agallocha diets and infected with E. coli and S. agalactiae are in 
agreement with the previous study by Laith [10, 22] in that E. 
agallocha has the potential as a dietary additive to mitigate 
mortality of fish infected with pathogenic bacteria. Therefore, 
the efficacy of in vivo assay may establish the antimicrobial 
action properties and provide a tailor-made alternative source to 
combat infectious agents. Hence, our findings revealed a potent 
in vitro and in vivo activity of the E. agallocha leaves extracts 
on pathogenic fish bacteria E. coli and S. agalactiae. 
 
Conclusion  
The results of the present study conclude crude extract of 
mangrove plants is a suitable agent in providing a non-
medicinal antimicrobial activity to combat bacterial infections 
in fish. Further work on the purification of bioactive 
compounds is currently underway to discover additional 
effective solutions for treating fish diseases. Therefore, we 
recommend the use of E. agallocha as an alternative therapeutic 
agent against both gram-negative and gram-positive bacterial 
infections in the aquaculture industry.   
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